Detection of Antibodies Against the CB9 to ICB10 Region of Merozoite Surface Protein-1 of Plasmodium Vivax Among the Inhabitants in Epidemic Areas

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2014 Aug 13

PMID 25113121

Citations 4

Authors

Tong-Soo Kim

Youngjoo Sohn

Jung-Yeon Kim

Won-Ja Lee

Byoung-Kuk Na

Yoon-Joong Kang

Hyeong-Woo Lee

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to examine the usefulness of the conserved block 9 (CB9) to interspecies conserved block (ICB10) region of Plasmodium vivax merozoite surface protein-1 (MSP-1 (ICB910)) as a serodiagnostic tool for understanding malaria transmission.

Methods: Antibody titre in the blood samples collected from the inhabitants of Gimpo city, Paju city and Yeoncheon county of Gyeonggi Province, as well as Cheorwon county of Gangwon Province, South Korea were determined by enzyme-linked immunosorbent assay (ELISA). Microscopic examination was performed to identify malarial parasites.

Results: MSP-1(ICB910) is encoded by a 1,212-bp sequence, which produced a recombinant protein with a molecular weight of approximately 46 kDa. Antibody titres in 1,774 blood samples were determined with the help of ELISA using purified recombinant MSP-1(ICB910). The overall ELISA-positive rate was 8.08% (n = 146). The annual parasite incidences (APIs) in the regions where the blood sampling was carried out gradually decreased from 2004 to 2005 (1.09 and 0.80, respectively). Yeoncheon county had the highest ELISA-positive rate (10.20%, 46/451). Yeoncheon county also had the highest API both in 2004 and 2005, followed by Cheorwon county, Paju city and Gimpo city.

Conclusions: The MSP-1 (ICB910)-ELISA-positive rates were closely related to API in the geographic areas studied. These results suggest that sero-epidemiological studies employing MSP-1 (ICB910)-ELISA may be helpful in estimating the prevalence of malaria in certain geographic areas. MSP-1(ICB910)-ELISA can be effectively used to establish and evaluate malaria control and eradication programmes in the affected areas.

Citing Articles

Identification and serological responses to a novel merozoite surface protein 1 (MSP-1) derived synthetic peptide: a putative biomarker for malaria exposure.

Marzano-Miranda A, Cardoso-Oliveira G, Carla de Oliveira I, Mourao L, Reis Cussat L, Fraga V PeerJ. 2024; 12:e17632.

PMID: 38948214 PMC: 11212635. DOI: 10.7717/peerj.17632.

Using Serological Markers for the Surveillance of Malaria: A Scoping Review.

Kartal L, Mueller I, Longley R Pathogens. 2023; 12(6).

PMID: 37375481 PMC: 10302697. DOI: 10.3390/pathogens12060791.

Sequence conservation of Plasmodium vivax glutamate dehydrogenase among Korean isolates and its application in seroepidemiology.

Seol B, Shin H, Kim J, Jeon B, Kang Y, Pak J Malar J. 2017; 16(1):3.

PMID: 28049479 PMC: 5209832. DOI: 10.1186/s12936-016-1653-3.

In vivo assessment of the antimalarial and spleen-protective activities of the Saudi propolis methanolic extract.

AlGabbani Q, Mansour L, Elnakady Y, Al-Quraishy S, Alomar S, Al-Shaebi E Parasitol Res. 2016; 116(2):539-547.

PMID: 27822584 DOI: 10.1007/s00436-016-5318-5.

References

Mendis K, Sina B, Marchesini P, Carter R . The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001; 64(1-2 Suppl):97-106. DOI: 10.4269/ajtmh.2001.64.97. View

McKenzie F, Prudhomme W, Magill A, Forney J, Permpanich B, Lucas C . White blood cell counts and malaria. J Infect Dis. 2005; 192(2):323-30. PMC: 2481386. DOI: 10.1086/431152. View

Duo-Quan W, Lin-Hua T, Zhen-cheng G, Xiang Z, Man-ni Y . Application of the indirect fluorescent antibody assay in the study of malaria infection in the Yangtze River Three Gorges Reservoir, China. Malar J. 2009; 8:199. PMC: 3224913. DOI: 10.1186/1475-2875-8-199. View

Collins W, Skinner J . The indirect fluorescent antibody test for malaria. Am J Trop Med Hyg. 1972; 21(5):690-5. DOI: 10.4269/ajtmh.1972.21.690. View

Engers H, Godal T . Malaria vaccine development: current status. Parasitol Today. 2006; 14(2):56-64. DOI: 10.1016/s0169-4758(97)01184-8. View

Lim K, Won Park J, Sohn M, Lee S, Oh J, Kim H . A direct sandwich ELISA to detect antibodies against the C-terminal region of merozoite surface protein 1 could be a useful diagnostic method to identify Plasmodium vivax exposed persons. Parasitol Res. 2002; 88(9):855-60. DOI: 10.1007/s00436-002-0594-7. View

Lee J, Kho W, Lee H, Seo M, Lee W . Current status of vivax malaria among civilians in Korea. Korean J Parasitol. 1998; 36(4):241-8. PMC: 2732963. DOI: 10.3347/kjp.1998.36.4.241. View

Dutta S, Ware L, Barbosa A, Ockenhouse C, Lanar D . Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Infect Immun. 2001; 69(9):5464-70. PMC: 98658. DOI: 10.1128/IAI.69.9.5464-5470.2001. View

Kim T, Kim J, Na B, Lee W, Kim H, Youn S . Decreasing incidence of Plasmodium vivax in the Republic of Korea during 2010-2012. Malar J. 2013; 12:309. PMC: 3844571. DOI: 10.1186/1475-2875-12-309. View

10.

Soares I, Levitus G, Souza J, del Portillo H, Rodrigues M . Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun. 1997; 65(5):1606-14. PMC: 175182. DOI: 10.1128/iai.65.5.1606-1614.1997. View

11.

Kaslow D, Kumar S . Expression and immunogenicity of the C-terminus of a major blood-stage surface protein of Plasmodium vivax, Pv200(19), secreted from Saccharomyces cerevisiae. Immunol Lett. 1996; 51(3):187-9. DOI: 10.1016/0165-2478(96)02570-9. View

12.

Na B, Lee H, Moon S, In T, Lin K, Maung M . Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. Parasitol Res. 2005; 96(5):321-5. DOI: 10.1007/s00436-005-1364-0. View

13.

Cho S, Kong Y, Park S, Lim Y, Chae S, Kho W . Two vivax malaria cases detected in Korea. Korean J Parasitol. 1994; 32(4):281-4. DOI: 10.3347/kjp.1994.32.4.281. View

14.

Pasay M, Cheng Q, Rzepczyk C, Saul A . Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. Mol Biochem Parasitol. 1995; 70(1-2):217-9. DOI: 10.1016/0166-6851(95)00015-s. View

15.

Moody A . Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002; 15(1):66-78. PMC: 118060. DOI: 10.1128/CMR.15.1.66-78.2002. View

16.

Paik Y, Ree H, Shim J . Malaria in Korea. Jpn J Exp Med. 1988; 58(2):55-66. View

17.

Chai I, Lim G, Yoon S, Oh W, Kim S, Chai J . [Occurrence of tertian malaria in a male patient who has never been abroad]. Korean J Parasitol. 1994; 32(3):195-200. DOI: 10.3347/kjp.1994.32.3.195. View

18.

Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan V . Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun. 2004; 72(10):5775-82. PMC: 517592. DOI: 10.1128/IAI.72.10.5775-5782.2004. View

19.

Cerutti Jr C, Boulos M, Coutinho A, Hatab M, Falqueto A, Rezende H . Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J. 2007; 6:33. PMC: 1839104. DOI: 10.1186/1475-2875-6-33. View

20.

Tsang V, Peralta J, Simons A . Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol. 1983; 92:377-91. DOI: 10.1016/0076-6879(83)92032-3. View